SA
Log In
HZNP
OverviewIntelligenceChart
+0.00%(+0.00)
Open
116.34
Prev Close
116.30
Day High
116.34
Day Low
116.30
Volume
23.9M
Avg Volume
23.9M
52W High
116.34
52W Low
116.30
Signal
Leaning Bearish1!
Price
1→
Move→+0.00%Quiet session
Volume
1→
Volume→1.0× avgNormal activity
Technical
1→
RSI↑RSI 84Overbought
PRICE
Prev Close
116.30
Open
116.34
Day Range116.30 – 116.34
116.30
116.34
52W Range116.30 – 116.34
116.30
116.34
0% of range
VOLUME & SIZE
Avg Volume
23.9M
FUNDAMENTALS
P/E Ratio
61.9x
Premium valuation
EPS (TTM)
—
Div Yield
No dividend
Beta
0.76
Low vol
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
75% gross margin
Valuation
EXPENSIVE
P/E 62x vs ~20x sector
Health
STRONG
CR 3.8 · FCF $4.94/sh
Bullish
Key MetricsTTM
Market Cap$26.60B
Revenue TTM$3.64B
Net Income TTM$438.00M
Free Cash Flow$906.13M
Gross Margin74.6%
Net Margin14.4%
Operating Margin17.0%
Return on Equity10.7%
Return on Assets5.7%
Debt / Equity0.51
Current Ratio3.85
EPS TTM$2.28
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
4 strong1 watch1 concern
67/100
Liquidity
3.85Strong
Leverage
0.51Strong
Coverage
7.4xStrong
ROE
10.7%Watch
ROIC
7.5%Concern
Cash
$2.4BStrong
ANALYST COVERAGE25 analysts
BUY
▲ +8.8%upside to target
L $110.00
Med $126.50consensus
H $144.00
Buy
1560%
Hold
1040%
15 Buy (60%)10 Hold (40%)0 Sell (0%)
Full report →
Stock Health
Composite Score
3 of 4 signals bullish
9/10
Technicals
●
RSI RangeRSI 84 — Overbought, caution
~
Fundamentals
●
Last EarningsBeat estimates
✓
●
Analyst ConsensusBuy
✓
●
LiquidityCurrent Ratio 3.85 — healthy liquidity
✓

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings ReportMay 6, 2026
Tomorrow
DEx-Dividend DateAug 3, 2026
In 90 days
PDividend PaymentAug 7, 2026
In 94 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBEARISH
Technicals →

Trend

→ PullbackGolden Cross · 50D leads 200D by 7.5%

+0.0% vs SMA 50 · +7.5% vs SMA 200

Momentum

RSI84.0
Overbought — pullback risk
MACD+0.00
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$116.3+0.0%
EMA 50
$116.3+0.0%
Current
$116.3
52W Low
$116.3+0.0%
EMA 200
$108.2-7.0%
52-Week RangeNear 52-week low
$116.30th %ile$116.3
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 6 analysts
Full estimates →
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$3.8B
$3.8B–$3.8B
—$2.03—
±28%
High6
FY2024
$4.2B
$4.2B–$4.2B
▲ +12.4%$2.35▲ +16.0%
±14%
High6
FY2025
$4.8B
$4.8B–$4.8B
▲ +12.7%$3.01▲ +27.8%
±8%
High5
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryHZNP
Last 8Q
+2.9%avg beat
Beat 6 of 8 quartersMissed 2↓ Estimates falling
+11%
Q1'22
+17%
Q2'22
-21%
Q3'22
+25%
Q4'22
+11%
Q1'23
-29%
Q2'23
+7%
Q3'23
+2%
Q4'23
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
BMO CapitalMarket Perform
Dec 13
DOWNGRADE
GuggenheimNeutral
Dec 13
DOWNGRADE
SVB LeerinkOutperform → Market Perform
Dec 13
DOWNGRADE
Wells FargoEqual-Weight
Dec 13
DOWNGRADE
SVB LeerinkOutperform
Aug 4
UPGRADE
Financials

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
NinePointTwo Capital LLC
0▼
2
Bartlett & Co. LLC
0▼
3
Simplicity Solutions, LLC
0▼
4
Kellner Capital, LLC
0▼
5
Desjardins Global Asset Management Inc.
0▼
6
Ergoteles LLC
122K▲
7
Berry Street Capital Management LLP
88K▼
8
Decheng Capital Management III (Cayman), LLC
79K—
News & Activity

HZNP News

20 articles · 4h ago

About

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The Company pipeline is purposeful: it applyie scientific expertise and courages to bring clinically meaningful therapies to patients. The Company believes science and compassion must work together to transform lives.

Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Website
www.horizontherapeutics.com ↗
Elizabeth ThompsonExecutive Vice President of R&D
Keli WalbertExecutive Vice President & Chief Marketing Officer

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance